Wholesale of pharmaceutical and medical goods
TLS CORE AS
Operating profit
NOK −35,000
Equity
NOK 20.4m
Incorporated
2014
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 35k | |
| Operating profit (EBIT) | −35k | |
| Net financial items | 6.6m | |
| Profit for the year | 6.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 23.1m | |
| of which current assets | 363k | |
| Equity | 20.4m | |
| Total liabilities | 2.7m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.